MX9702381A - Medicamentos hormonales nuevos y su uso para corregir deficiencias de estrogeno. - Google Patents
Medicamentos hormonales nuevos y su uso para corregir deficiencias de estrogeno.Info
- Publication number
- MX9702381A MX9702381A MX9702381A MX9702381A MX9702381A MX 9702381 A MX9702381 A MX 9702381A MX 9702381 A MX9702381 A MX 9702381A MX 9702381 A MX9702381 A MX 9702381A MX 9702381 A MX9702381 A MX 9702381A
- Authority
- MX
- Mexico
- Prior art keywords
- correcting
- oestrogen
- unit doses
- doses containing
- hormonal medicaments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
La invencion pertenece al campo de la química terapéutica. Más precisamente, el objeto de la invencion es una combinacion hormonal trisecuencial, estroprogestativa, caracterizada porque comprende unidad de dosis que contiene solamente un estrogeno, unidad de dosis que contiene una combinacion de un estrogeno y un progestágeno y una unidad de dosis que contiene solamente un portador. El modo de suministro trisecuencial ayuda en compensar los desordenes funcionales provocados por hipoestrogenismo menopáusico o pre-menopáusico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9509364A FR2737411B1 (fr) | 1995-08-01 | 1995-08-01 | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
PCT/IB1996/000754 WO1997004784A1 (fr) | 1995-08-01 | 1996-07-29 | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9702381A true MX9702381A (es) | 1998-02-28 |
Family
ID=9481610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9702381A MX9702381A (es) | 1995-08-01 | 1996-07-29 | Medicamentos hormonales nuevos y su uso para corregir deficiencias de estrogeno. |
Country Status (31)
Country | Link |
---|---|
US (1) | US5891867A (es) |
EP (1) | EP0783310B1 (es) |
JP (1) | JPH10507207A (es) |
KR (1) | KR100450649B1 (es) |
CN (1) | CN1138547C (es) |
AP (1) | AP829A (es) |
AR (1) | AR004502A1 (es) |
AT (1) | ATE225659T1 (es) |
AU (1) | AU722355B2 (es) |
BR (1) | BR9606549A (es) |
CA (1) | CA2201368C (es) |
CZ (1) | CZ289706B6 (es) |
DE (1) | DE69624214T2 (es) |
DK (1) | DK0783310T3 (es) |
DZ (1) | DZ2078A1 (es) |
ES (1) | ES2184880T3 (es) |
FR (1) | FR2737411B1 (es) |
HK (1) | HK1005227A1 (es) |
HU (1) | HU229843B1 (es) |
IL (1) | IL120558A (es) |
MA (1) | MA23946A1 (es) |
MX (1) | MX9702381A (es) |
MY (1) | MY117307A (es) |
NO (1) | NO312996B1 (es) |
OA (1) | OA10411A (es) |
PT (1) | PT783310E (es) |
RU (1) | RU2188641C2 (es) |
TN (1) | TNSN96101A1 (es) |
TW (1) | TW473390B (es) |
WO (1) | WO1997004784A1 (es) |
ZA (1) | ZA966545B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030355A1 (fr) * | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
FR2754179B1 (fr) * | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
FR2814074B1 (fr) * | 2000-09-15 | 2003-03-07 | Theramex | Nouvelles compositions estro-progestatives topiques a effet systemique |
US20020151732A1 (en) * | 2001-01-05 | 2002-10-17 | Claes Ohlsson | Estrogen receptors |
US20030004145A1 (en) * | 2001-05-16 | 2003-01-02 | Leonard Thomas W. | Treatment of conditions relating to hormone deficiencies by administration of progestins |
HU230759B1 (hu) * | 2001-12-05 | 2018-03-28 | Teva Women's Health, Inc. | Teherbeesés megakadályozására és menstruációs tünetek enyhítésére vagy kiküszöbölésére alkalmas orális készítmények |
US7008979B2 (en) * | 2002-04-30 | 2006-03-07 | Hydromer, Inc. | Coating composition for multiple hydrophilic applications |
NZ585546A (en) * | 2003-07-16 | 2011-10-28 | Teva Womens Health Inc | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
US8022053B2 (en) * | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
US20080242650A1 (en) * | 2007-03-26 | 2008-10-02 | Jean-Louis Thomas | Oral contraceptive regimen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
FR2695826B1 (fr) * | 1992-09-21 | 1995-01-06 | Theramex | Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention. |
-
1995
- 1995-08-01 FR FR9509364A patent/FR2737411B1/fr not_active Expired - Fee Related
-
1996
- 1996-07-22 MA MA24321A patent/MA23946A1/fr unknown
- 1996-07-26 MY MYPI96003099A patent/MY117307A/en unknown
- 1996-07-29 ES ES96923018T patent/ES2184880T3/es not_active Expired - Lifetime
- 1996-07-29 EP EP96923018A patent/EP0783310B1/fr not_active Expired - Lifetime
- 1996-07-29 HU HU9900612A patent/HU229843B1/hu unknown
- 1996-07-29 AP APAP/P/1997/000979A patent/AP829A/en active
- 1996-07-29 AU AU63674/96A patent/AU722355B2/en not_active Expired
- 1996-07-29 IL IL12055896A patent/IL120558A/en not_active IP Right Cessation
- 1996-07-29 AT AT96923018T patent/ATE225659T1/de active
- 1996-07-29 RU RU97108279/14A patent/RU2188641C2/ru active
- 1996-07-29 BR BR9606549A patent/BR9606549A/pt not_active Application Discontinuation
- 1996-07-29 US US08/817,329 patent/US5891867A/en not_active Expired - Lifetime
- 1996-07-29 WO PCT/IB1996/000754 patent/WO1997004784A1/fr not_active Application Discontinuation
- 1996-07-29 CZ CZ1997967A patent/CZ289706B6/cs not_active IP Right Cessation
- 1996-07-29 JP JP9507406A patent/JPH10507207A/ja not_active Ceased
- 1996-07-29 CA CA2201368A patent/CA2201368C/fr not_active Expired - Lifetime
- 1996-07-29 KR KR1019970702125A patent/KR100450649B1/ko not_active IP Right Cessation
- 1996-07-29 CN CNB96191100XA patent/CN1138547C/zh not_active Expired - Lifetime
- 1996-07-29 DK DK96923018T patent/DK0783310T3/da active
- 1996-07-29 MX MX9702381A patent/MX9702381A/es active IP Right Grant
- 1996-07-29 PT PT96923018T patent/PT783310E/pt unknown
- 1996-07-29 DE DE69624214T patent/DE69624214T2/de not_active Expired - Lifetime
- 1996-07-30 DZ DZ960122A patent/DZ2078A1/fr active
- 1996-07-31 AR ARP960103818A patent/AR004502A1/es not_active Application Discontinuation
- 1996-08-01 TN TNTNSN96101A patent/TNSN96101A1/fr unknown
- 1996-08-01 ZA ZA966545A patent/ZA966545B/xx unknown
- 1996-09-24 TW TW085111673A patent/TW473390B/zh not_active IP Right Cessation
-
1997
- 1997-03-26 NO NO19971449A patent/NO312996B1/no not_active IP Right Cessation
- 1997-04-01 OA OA60985A patent/OA10411A/fr unknown
-
1998
- 1998-05-25 HK HK98104497A patent/HK1005227A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9702381A (es) | Medicamentos hormonales nuevos y su uso para corregir deficiencias de estrogeno. | |
MX9602683A (es) | Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas. | |
EP1028715A4 (en) | FORMULATION FOR NASAL SUPPORT AND METHOD OF USE THEREOF | |
PL330916A1 (en) | Progestagen-antiprogestagen dosing schemes | |
MX9605023A (es) | Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas. | |
GEP20063773B (en) | Steroid Sulphatase Inhibitors | |
IL125534A (en) | Unit dose of budesonide and use thereof for nasal administration | |
MY124574A (en) | Dispenser | |
MY101778A (en) | Multiphase combined preparation and its use for oral contraception | |
UA29451C2 (uk) | Спосіб збереження або збільшення щільності кістки або інгібування втрати кісткової маси | |
NZ298769A (en) | use of progesterone-antagonistic and anti-estrogen compounds in a single dose for female contraception | |
AU7496894A (en) | Antiglucocorticoid steroids for the treatment of anxiety disorders | |
CA2270177A1 (en) | Transdermal administration of ment | |
AP1901A (en) | Pharmaceutical composition for modified release insulin sensitiser. | |
ZA963743B (en) | Transdermal therapeutic system (TTS) for the administration of testosterone | |
EP1090639A3 (en) | Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator | |
BG103060A (en) | 19-nor-holan steroids as neurochemical initiators of the change of the operation of the hypothalamus in human organism | |
MX9702253A (es) | Nuevos estrenos para inducir efectos hipotalamicos | |
MY115795A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | |
NO955347D0 (no) | Hormonelt middel for terapi av akne samt anvendelse derav | |
AU7718796A (en) | 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus | |
ES2065855A1 (es) | Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos. | |
AU2691197A (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
DE59900775D1 (de) | Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische präparate | |
WO1996028154A3 (de) | Verwendung von antiestrogenen zur männlichen fertilitätskontrolle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |